![CD5: from antiquated T cell marker to immunotherapy's new hope | Signal Transduction and Targeted Therapy CD5: from antiquated T cell marker to immunotherapy's new hope | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-023-01494-5/MediaObjects/41392_2023_1494_Fig1_HTML.png)
CD5: from antiquated T cell marker to immunotherapy's new hope | Signal Transduction and Targeted Therapy
![Both CD5 + and CD5 -are negative for markers of activation, CD80 and... | Download Scientific Diagram Both CD5 + and CD5 -are negative for markers of activation, CD80 and... | Download Scientific Diagram](https://www.researchgate.net/publication/350913820/figure/fig3/AS:1019788902019079@1620148029992/Both-CD5-and-CD5-are-negative-for-markers-of-activation-CD80-and-CD86-directly-ex.png)
Both CD5 + and CD5 -are negative for markers of activation, CD80 and... | Download Scientific Diagram
![CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41423-020-0490-z/MediaObjects/41423_2020_490_Fig1_HTML.png)
CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology
![CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0e7bf121-6aed-4521-8f66-3cc965ded438/eji4680-gra-0001-m.jpg?trick=1695150505589)
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library
![T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-022-00898-z/MediaObjects/41392_2022_898_Fig2_HTML.png)
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy
![T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00898-z/MediaObjects/41392_2022_898_Fig1_HTML.png)
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy
![Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//25311379/0000004200000003/v3_202009160753/S2531137919301324/v3_202009160753/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR3zJSEmH4GGT8A27de8H5QqAdccHlDwud9PYwTAyLTEDuwOiqSIbmQdF3kQjsu6ZxfmiEEQScQL0HaNU4BZ6JUmiNAe18YowduLzZpY6WeB6lJgNJxbrR34jguMIAGx+MMRIU9MG+/EPacfpihk7jdSOvDzZn0xDXWyCamRK5uMWFDK57MFioLhLXq4zFhD9lv34mSG86a6/F5odFfHb8uyPkKTi13t3zADyhuEHuhVTs5rHypMVsD8AR5XHnl0LNKIVgUF7OVvf/Y4piJZ3stY)
Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy
![Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram](https://www.researchgate.net/publication/11360352/figure/fig2/AS:281749927022611@1444185825802/Expression-of-surface-membrane-markers-on-B-CLL-cells-and-normal-CD5-B-cells-Surface.png)
Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram
![Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram](https://www.researchgate.net/publication/11360352/figure/fig1/AS:281749927022610@1444185825678/Expression-of-surface-membrane-markers-on-B-CLL-cells-and-normal-CD5-B-cells-Surface.png)
Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram
![Cancers | Free Full-Text | Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias Cancers | Free Full-Text | Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias](https://www.mdpi.com/cancers/cancers-14-00524/article_deploy/html/images/cancers-14-00524-g001.png)
Cancers | Free Full-Text | Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias
![Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function](https://www.frontiersin.org/files/MyHome%20Article%20Library/584937/584937_Thumb_400.jpg)
Frontiers | Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function
![Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram](https://www.researchgate.net/publication/47791483/figure/fig5/AS:601636112199696@1520452635473/Effect-of-CD5-enhancer-deletion-on-CD5-expression-on-splenic-T-cells-Splenocytes-were.png)